Fractyl Health
GUTS
62 hedge funds and large institutions have $44.9M invested in Fractyl Health in 2025 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 14 increasing their positions, 20 reducing their positions, and 22 closing their positions.
51% more capital invested
Capital invested by funds: $29.7M → $44.9M (+$15.2M)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
5.55% more ownership
Funds ownership: 50.99% → 56.54% (+5.5%)
5% less funds holding
Funds holding: 65 → 62 (-3)
14% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 22
30% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCGM
General Catalyst Group Management
Cambridge,
Massachusetts
|
+$7.89M |
| 2 |
Millennium Management
New York
|
+$827K |
| 3 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$180K |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$131K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$129K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$2.54M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$654K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$309K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$289K |
| 5 |
State Street
Boston,
Massachusetts
|
-$197K |
GUTS Hedge Fund Activity: Q2 2025 in Review
62 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Fractyl Health (GUTS) for Q2 2025, worth a combined $44.9M — up 51% from $29.7M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of GUTS and 19 opened new positions — a net loss of 3 holders — while 20 trimmed existing stakes and 14 added.
The largest buyer was General Catalyst Group Management, opening a new position worth an estimated $7.89M. The largest seller was BlackRock, cutting an estimated $2.54M.
- 62 institutional investors held Fractyl Health (GUTS) as of Q2 2025, down from 65 in Q1 2025.
- Funds reported $44.9M of Fractyl Health stock for Q2 2025, up 51% quarter-over-quarter.
- 19 funds opened new Fractyl Health positions in Q2 2025 and 22 closed out, a net change of -3 holders.
- The largest Fractyl Health buyer in Q2 2025 was General Catalyst Group Management, an estimated $7.89M added.
- The largest Fractyl Health seller in Q2 2025 was BlackRock, an estimated $2.54M sold.
Based on aggregated 13F filings for Q2 2025.